$Trump Media & Technology (DJT.US)$ Good health shares. If y...

Good health shares. If you have time, pay attention to the CYBN stock. Hey, CYBN produces psychedelic mushroom preparations. Psychedelic mushrooms are a future star for treating depression, mental illness... various mental and mental illnesses. CYBN has now entered phase 3 human testing. Friends who think their stocks are promising can start now. The stock price is ultra-low at 0.375 yuan, making it suitable for long-term holding. As an additional note, the first psychedelic mushroom treatment clinic in the US was established in Oregon in 2024. Johns Hopkins Medical Group used a donation of $17 million to build the Psychedelic Drug Research Center, which will become the first and largest psychedelic mushroom research center in the US and the world.